L
listener
Guest
http://archinte.ama-assn.org/cgi/content/abstract/164/1/40?maxtoshow=
"In randomized trials of secondary prevention, pravastatin sodium and aspirin reduce risks of
cardiovascular disease. Pravastatin has a predominantly delayed antiatherogenic effect, and aspirin
has an immediate antiplatelet effect, raising the possibility of additive clinical benefits. "
...
"More widespread and appropriate combined use of statins and aspirin in secondary prevention of
cardiovascular disease will avoid large numbers of premature deaths. "
L.
"In randomized trials of secondary prevention, pravastatin sodium and aspirin reduce risks of
cardiovascular disease. Pravastatin has a predominantly delayed antiatherogenic effect, and aspirin
has an immediate antiplatelet effect, raising the possibility of additive clinical benefits. "
...
"More widespread and appropriate combined use of statins and aspirin in secondary prevention of
cardiovascular disease will avoid large numbers of premature deaths. "
L.